Clinical Trial

Effect of CYP2D6*10 Gene Mutation on Perioperative Precision Analgesia of Oxycodone in Elderly Patients

Completed
View on ClinicalTrials.gov →
Summary
The purpose of this prospective study was to determine the effect of CYP2D6 gene polymorphism on perioperative analgesia of oxycodone in elderly patients, and to assign the CYP2D6 phenotype according to the genotype, and to use inhibitors for pain control of phenotype conversion. The significance is to accurately guide the perioperative analgesia of oxycodone in elderly patients, and to more effectively avoid toxicity and adverse reactions.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-18.
Trial Details
NCT Number NCT07484867
Lead Sponsor Henan Provincial People's Hospital
Conditions Pain, Pulmonary Nodules, Oxycodone
Enrollment 100 participants
Start Date 2025-01-01
Primary Completion 2025-06-15 (estimated)
Study Completion 2025-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-12